Abstract:
본 발명은 C3G (Cyanidin-3-O-β-d-glucopyranoside) 의 당뇨병성 방광병증 개선의 효능에 기초한 것으로, 구체적으로, 본 발명은 C3G 를 포함하는 당뇨병성 방광병증의 예방 또는 치료용 약학 조성물 및 건강기능용 식품 조성물에 관한 것이다. 또한, 본 발명은 C3G 를 함유하는 오디 추출물을 포함하는 당뇨병성 방광병증의 예방 또는 치료용 약학 조성물 및 건강기능용 식품 조성물에 관한 것이다.
Abstract:
PURPOSE: A composition containing cyanidin-3-O-beta-d-glucopyranoside (C3G) or a mulberry extract containing C3G is provided to effectively and safely treat diabetic cystopathy without toxicity and side effects. CONSTITUTION: A pharmaceutical composition for preventing or treating diabetic cystopathy contains C3G which is derived from mulberry. The pharmaceutical composition contains a mulberry extract containing C3G. The pharmaceutical composition additionally contains a pharmaceutically acceptable carrier. A health food composition for treating diabetic cystopathy contains C3G.
Abstract:
PURPOSE: A composition containing anthocyanin isolated from black soybeans for preventing and treating varicocele or male infertility is provided to reduce oxidative stress, and to reduce oxidative DNA damages in the testis. CONSTITUTION: A pharmaceutical composition for preventing and treating varicocele or male infertility contains 15-35 wt% of delphinidin-3-O-glucoside, 55-75 wt% of cyanidin-3-O-glucoside, and 1-10 wt% of petunidin-3-O-glucoside.